- Home
- HBNC vs AMLX Comparison
HBNC vs AMLX Comparison
Compare HBNC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBNC
- AMLX
- Stock Information
- Founded
- HBNC 1873
- AMLX 2014
- Country
- HBNC United States
- AMLX United States
- Employees
- HBNC N/A
- AMLX N/A
- Industry
- HBNC Major Banks
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- HBNC Finance
- AMLX Health Care
- Exchange
- HBNC Nasdaq
- AMLX Nasdaq
- Market Cap
- HBNC 706.4M
- AMLX 749.9M
- IPO Year
- HBNC N/A
- AMLX 2022
- Fundamental
- Price
- HBNC $16.34
- AMLX $8.96
- Analyst Decision
- HBNC Hold
- AMLX Strong Buy
- Analyst Count
- HBNC 2
- AMLX 7
- Target Price
- HBNC $18.00
- AMLX $12.00
- AVG Volume (30 Days)
- HBNC 371.8K
- AMLX 1.1M
- Earning Date
- HBNC 10-22-2025
- AMLX 08-07-2025
- Dividend Yield
- HBNC 4.09%
- AMLX N/A
- EPS Growth
- HBNC 170.74
- AMLX N/A
- EPS
- HBNC 1.17
- AMLX N/A
- Revenue
- HBNC $211,582,000.00
- AMLX N/A
- Revenue This Year
- HBNC $47.63
- AMLX N/A
- Revenue Next Year
- HBNC $4.03
- AMLX N/A
- P/E Ratio
- HBNC $13.38
- AMLX N/A
- Revenue Growth
- HBNC 19.27
- AMLX N/A
- 52 Week Low
- HBNC $12.70
- AMLX $2.05
- 52 Week High
- HBNC $19.18
- AMLX $9.38
- Technical
- Relative Strength Index (RSI)
- HBNC 52.60
- AMLX 60.85
- Support Level
- HBNC $14.84
- AMLX $7.63
- Resistance Level
- HBNC $15.84
- AMLX $9.38
- Average True Range (ATR)
- HBNC 0.34
- AMLX 0.48
- MACD
- HBNC -0.01
- AMLX 0.04
- Stochastic Oscillator
- HBNC 69.93
- AMLX 76.92
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.